USPSTF Prevention TaskForce vs Yellow Card

The Prevention TaskForce (formerly ePSS) is an application designed and developed by the U.S. Department of Health & Human Services (HHS), Agency for Healthcare Research and Quality (AHRQ), the Nation's lead Federal agency for research on health care quality, costs, outcomes and patient safety. It was developed by AHRQ to support the independent U.S. Preventive Services Task Force (USPSTF). The USPSTF is an independent, volunteer panel of national experts in prevention and evidence-based medicine. AHRQ provides support to the USPSTF. The Prevention TaskForce application was developed to assist primary care clinicians identify the screening, counseling, and preventive medication services that are appropriate for their patients. The Prevention TaskForce information is based on the current recommendations of the U.S. Preventive Services Task Force (USPSTF) and can be searched by specific patient characteristics, such as age, sex, and selected behavioral risk factors. When using this tool please read the specific recommendation to determine if the preventive service is appropriate for your patient. This tool is not meant to replace clinical judgment and individualized patient care. *Application downloads and data updates require internet connectivity

Use the Yellow Card app to report suspected safety concerns involving healthcare products, including a side effect with a medicine or an adverse medical device incident. The Yellow Card scheme is the UK system run by the MHRA* for collecting and monitoring information on suspected adverse reactions to all medicines including vaccines, blood factors and immunoglobulins, herbal medicines and homeopathic remedies, and all medical devices available on the UK market. The Yellow Card app allows users to: Report safety concerns about: > Suspected side effects to a medicine or vaccine (including herbal products and homeopathic remedies) > Adverse incidents involving a medical device (including software, apps and artificial intelligence) > Suspected defective medicines (a product that is not working properly or not to the manufacturer’s specifications) > Fake and/or unauthorised medicines > Blood products Create an account: > View previously submitted reports > Update your reports > Create a watchlist for alerts to products of interest > Track new safety information published by the MHRA > View numbers of reports received by the MHRA All reports received through the app or website can help the MHRA identify potential new concerns about a medicine, vaccine or medical device and act as an early warning for further investigation. The MHRA will review the product if necessary, and take action to minimise risk and maximise benefit to the patients. *The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive Agency of the Department of Health and Social Care; the MHRA protects and promotes public health and patient safety by ensuring that medicines, healthcare products and medical equipment are used safely and meet appropriate standards of safety, quality, performance and effectiveness.